Business ❯Pharmaceuticals

Eli Lilly

Weight-loss drugs Sales Supply and demand Earnings Tirzepatide First Quarter Financial Performance Donanemab Financial Guidance Investment Alzheimer's Disease

U.S. Markets Close Holiday Week Deep in the Red as Volatility Persists

Major indices tumbled further, with corporate earnings shocks and trade policy uncertainty amplifying investor concerns.

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales

Wall Street Braces for Inflation and Earnings Data Amid Market Uncertainty